Genetic diversity mapping, complete genotype-phenotype associations, and bioinformatic analyses of Hb variants, have been shown to be useful in guiding haemoglobinopathy control and treatment options in the population of Southern China. The gene discussed is GSTM1; the disease is hemoglobinopathy.